MEZOO Co., Ltd.
KKRX:0088M012,680.00
KRW
-620.00
(-4.66%)
ISIN
KR70088M0003
Return %
Stock
S&P 500
1Y
- -
13.14
3Y
- -
80.78
5Y
- -
67.74
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.Company Description
- Sector
- Health technology
- Industry
- Medical specialties
- Address
- Wonju-si South Korea
- IPO Date
- Mar 26, 2026
- Website
- me-zoo.com
- Similar Companies
- Business
- MEZOO Co., Ltd. is a South Korea-based digital healthcare and medical device company that specializes in the development, manufacturing, and commercialization of wearable ambulatory Remote Patient Monitoring (aRPM) solutions and artificial intelligence-driven biosignal measurement platforms. The company offers a comprehensive portfolio of diagnostic and continuous monitoring solutions, including HiCardi, a lightweight, patch-type electrocardiogram (ECG) monitor; HiCardi+, an advanced wearable sensor designed for continuous cardiac telemetry that detects up to 17 types of arrhythmias in real time; HiCardi M350, an integrated multi-parameter patch tracking ECG, heart rate, respiratory rate, surface temperature, and pulse oximetry (SpO2); SmartPatch, an ultra-compact biosignal sensor for inpatient and outpatient use; SmartView, a mobile patient gateway application for vital sign visualization and cloud transmission; LiveStudio, a centralized hospital ward monitoring software platform for medical staff; and VetCardi, a dedicated veterinary cardiac monitoring solution for companion animals. The company serves tertiary general hospitals, clinics, clinical research centers, and home-care patients. In recent developments, MEZOO completed its initial public offering on the KOSDAQ market under the ticker symbol 0088M0, broadened domestic adoption across more than 800 medical institutions through an exclusive distribution partnership with Dong-A ST Co., Ltd., and accelerated global market penetration through an international supply and distribution agreement with Schiller Asia Pacific to distribute HiCardi products across Thailand, Malaysia, the Philippines, Taiwan, Australia, and Singapore, alongside ongoing market expansion in Latin America. Founded in 2007 and incorporated in 2018, MEZOO Co., Ltd. is headquartered in Wonju-si, Gangwon-do, South Korea.